When was Pharmacelera founded?

Pharmacelera was founded in 2015 and raised its 1st funding round 3 years after it was founded.

Where is Pharmacelera located?

Pharmacelera is headquartered in Barcelona, Spain.

Who is the current CEO of Pharmacelera?

Enric Gibert Codina of Pharmacelera. They have also founded 1 company.

How many employees does Pharmacelera have?

As of May 31, 2026, the latest employee count at Pharmacelera is 28.

Is Pharmacelera a funded company?

Pharmacelera is a funded company, having raised a total of $7.1M across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jun 01, 2018.

When was the latest funding round of Pharmacelera?

Pharmacelera's latest funding was a $***** Series A round on Feb 18, 2026, with participation from 4 investors. Its primary sector is Life Sciences Tech. In Spain, the Life Sciences Tech sector has seen $59.1M in funding in 2026 to date.

Where does Pharmacelera rank among its competitors?

Pharmacelera ranks 4th amongst 179 active competitors, of which 43 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Cartography Biosciences, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Pharmacelera?

Pharmacelera's top competitors include Certara, Cartography Biosciences and TOLREMO therapeutics. Among them, Cartography Biosciences secured the most recent funding round in May, 2026.

Pharmacelera - 2026 Company Profile, Team, Funding & Competitors

Company Details

Hardware and software solutions for computer-aided drug design. Products include PharmScreen- a ligand-based virtual screening tool that uses a 3D ligand-alignment algorithm based on the interaction fields for lead generation, and PharmQSAR- a 3D Quantitative Structure-Activity Relationship (QSAR) tool able to combine multiple fields of interaction.

Website: pharmacelera.com
Social
Email ID: *****@pharmacelera.com

Key Metrics

Founded Year

2015

Location

Barcelona, Spain

Stage

Series A

Total Funding

$7.1M in 6 rounds

Latest Funding Round

Series A, Feb 18, 2026, $*****

Investors

HERAN Partners & 7 more

Ranked

4^th among 179 active competitors

Employee Count

28 as on May 31, 2026

Similar Companies

Certara & 245 more

View Pharmacelera's full profile

Pharmacelera has raised a total funding of $7.1M over 6 rounds. Its first funding round was on Jun 01, 2018. Its latest funding round was a Series A round on Feb 18, 2026 for $*****. 4 investors participated in its latest round. Pharmacelera has 8 institutional investors.

Here is the list of recent funding rounds of Pharmacelera:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 18, 2026	7687801	Series A	5118197	5063220	9543382	7352544
Aug 31, 2022	9258361	Grant (prize money)	1102429	6832289	2668415	EIC Fund
Sep 01, 2020	6145385	Grant (prize money)	9674019	3089790	2167926	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Pharmacelera's funding rounds and investors

The founders of Pharmacelera are Enric Herrero and Enric Gibert Codina. Enric Gibert Codina is the CEO of Pharmacelera.

Here are the details of Pharmacelera's key team members:

Enric Herrero: Co-Founder & CTO of Pharmacelera.
Contact Info: 1 email address
Enric Gibert Codina: Co-Founder & CEO of Pharmacelera.

View details of Pharmacelera's Founder profiles and Board Members

Pharmacelera's employee count trend

Pharmacelera has 28 employees as of May 26. Here is Pharmacelera's employee count trend over the years:

Uncover Pharmacelera's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pharmacelera include Certara, Cartography Biosciences and TOLREMO therapeutics. Here is the list of Top 10 competitors of Pharmacelera, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Certara 2008, Princeton (United States), Public	Provider of a platform for in silico drug discovery and consulting services	-	HTIF, Mubadala & 3 others	65/100
2nd	Cartography Biosciences 2020, Foster City (United States), Series B	Provider of a platform to discover immunotherapeutics	$124M	Pfizer, 8VC & 19 others	62/100
3rd	TOLREMO therapeutics 2017, Zurich (Switzerland), Series A	Developing anti-cancer small molecules targeting novel drug resistance pathways	$55.8M	BioMedPartners, Altos Ventures Management ... & 9 others	60/100
4th	Pharmacelera 2015, Barcelona (Spain), Series A	Hardware and software solutions for computer-aided drug design	$7.1M	Intelectium, Inveready & 6 others	59/100
5th	Oxford Drug Design 2001, Oxford (United Kingdom), Series A	Provider of computer-aided design of antibiotics for MDR infections	$12.4M	o2h ventures, ACF Investors & 55 others	59/100
6th	Inpharmatica 1998, London (United Kingdom), Acquired	Developer of predictive informatics based platform for drug discovery	$75M	Vertex Ventures, Kreos Capital & 6 others	58/100
7th	HotSpot Therapeutics 2017, Boston (United States), Series C	Developer of a platform for protein function analysis	$210M	Pivotal bioVenture Partners, Atlas Venture ... & 14 others	56/100
8th	Genialis 2015, Boston (United States), Series A	Developer of end-to-end bioinformatics software solutions	$16M	Taiwania Capital, Redalpine & 9 others	56/100
9th	BioMap 2020, Beijing (China), Series A	AI-based precision medicine supporting tool for drug discovery	-	GGV Capital, Legend Capital & 4 others	55/100
10th	Probius 2016, Fremont (United States), Seed	Digital biochemical analysis tool for healthcare researchers	$2.44M	Baidu Ventures, Cota Capital & 8 others	55/100